ArticleActa pharmaceutica Sinica. B2022

MET inhibitor tepotinib antagonizes multidrug resistance mediated by ABCG2 transporter:

Zhuo-Xun Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.